Magnetic resonance imaging (MRI) is one of the most advanced non-invasive neuroimaging techniques in common use. In 1990, Ogawa et al.1 found that MRI can be used to obtain functional information about the brain. This modality is commonly known as functional MRI (fMRI). fMRI measures indirect effects of neuronal activities in a brain region due to changes in magnetic susceptibility between oxygenated and deoxygenated blood. This type of signal is called the blood oxygenation level dependent (BOLD) signal. Being paramagnetic, deoxyhemoglobin causes slightly more local inhomogeneity in the local magnetic field, in turn causing slightly faster dephasing of the spins (of hydrogen ions in the water molecules) compared to the diamagnetic oxyhemoglobin. This change in spin dephasing causes a small change in local T2* relaxation time, but it is enough to measure by statistical analysis of the MRI signal. BOLD signal changes are observed in both task fMRI and rest fMRI.2,3
Purpose: Currently, functional magnetic resonance imaging (fMRI) is the most commonly used technique for obtaining dynamic information about the brain. However, because of the complexity of the data, it is often difficult to directly visualize the temporal aspect of the fMRI data. Approach: We outline a t-distributed stochastic neighbor embedding (t-SNE)-based postprocessing technique that can be used for visualization of temporal information from a 4D fMRI data. Apart from visualization, we also show its utility in detection of major changes in the brain meta-states during the scan duration. Results: The t-SNE approach is able to detect brain-state changes from task to rest and vice versa for single- and multitask fMRI data. A temporal visualization can also be obtained for task and resting state fMRI data for assessing the temporal dynamics during the scan duration. Additionally, hemodynamic delay can be quantified by comparison of the detected brain-state changes with the experiment paradigm for task fMRI data. Conclusion: The t-SNE visualization can visualize help identify major brain-state changes from fMRI data. Such visualization can provide information about the degree of involvement and attentiveness of the subject during the scan and can be potentially utilized as a quality control for subject’s performance during the scan.
19 January 2026 in Journal of Alzheimer's Disease Reports
FIFor The Alzheimer'S Disease Neuroimaging Initiative
For The Alzheimer'S Disease Neuroimaging Initiative
Background: Accurate diagnosis of Alzheimer's disease (AD) is both challenging and time consuming. With a systematic approach to diagnosis, steps can be taken toward improved treatment and prevention of the disease. Objective: This study explores the practical application of deep learning models for the diagnosis of AD across different disease stages. Methods: Due to computational complexity, long training times, and limited availability of labeled datasets, full brain three-dimensional (3D) convolutional neural networks (CNNs) are not commonly used, and many studies rely on two-dimensional (2D) variants. In this work, full brain 3D versions of well-known 2D CNN architectures were designed, trained, and tested for the diagnosis of multiple stages of AD. More than 1500 full brain volumes were used for model training and evaluation. Results: The proposed deep learning approach demonstrated good performance in differentiating various stages of AD. In addition to classification, the models were able to extract discriminative features relevant to disease stage. These features aligned with meaningful anatomical landmarks that are currently considered important for AD identification by clinical experts. An ensemble of all algorithms was also evaluated and achieved superior performance compared to individual models, with a maximum classification accuracy of 87.4%. Conclusions: The trained 3D CNNs and their ensemble show strong potential for assisting in the diagnosis of AD. These models may be incorporated into clinical software tools to support physicians and radiologists in improved diagnostic decision making.
Decision making is a complex process involving various parts of the brain which are active during different times. It is challenging to measure externally the exact instant when any given region becomes active during the decision-making process. Here, we propose the development and validation of an algorithm to extract and visualize the dynamic functional brain activation information from the observed fMRI data. We propose the use of a regularized deconvolution model to simultaneously map various activation regions within the brain and track how different activation regions changes with time, thus providing both spatial and temporal brain activation information. The proposed technique was validated using simulated data and then applied to a simple decision-making task for identification of various brain regions involved in different stages of decision making. Using the results of the dynamic activation for the decision-making task, we were able to identify key brain regions involved in some of the phases of decision making. The visualization aspect of the algorithm allows us to actually see the flow of activation (and deactivation) in the form of a motion picture. The dynamic estimate may aid in understanding the causality of activation between various brain regions in a better way in future fMRI brain studies.
17 March 2024 in 2020 IEEE Southwest Symposium on Image Analysis and Interpretation (SSIAI)
Resting state functional Magnetic Resonance Imaging (rs-fMRI) is used to obtain spontaneous activation within the human brain in the absence of specific tasks. Analysis of the rs-fMRI data required spatially and functionally homogenous parcellation of the whole brain based on underlying temporal fluctuations. Commonly used parcellation schemes have a tradeoff between intra-cluster functional similarity and alignment with anatomical regions. In this article, we present a clustering scheme for rs-fMRI data that obtains spatially and functionally homogenous clusters. Results show that the proposed multistage approach can identify various brain networks. Moreover, the functional homogeneity of the clusters is shown to be better than those found with functional atlas and simple k-means clusters. The spatial homogeneity is shown to be better than Independent Component Analysis (ICA), and simple k-means clusters.
Prolonged grief disorder (PGD) affects approximately 10% of bereaved individuals and is now formally recognized in both the DSM-5-TR and ICD-11. Despite its prevalence, PGD often responds poorly to traditional therapeutic approaches. This manuscript outlines the protocol for an early-stage open-label feasibility trial investigating the use of psilocybin, a psychedelic compound, in treating PGD in adults, with a focus on young adults. The study will involve 20 participants diagnosed with PGD. Each participant will undergo a structured therapeutic process that includes a preparatory session, a single 25 mg dose of psilocybin, and post-session integration. Throughout the study, participants will be monitored via symptom assessments, including qualitative and quantitative data, with the main aims related to safety, feasibility and acceptability. Functional MRIs will be obtained pre- and post-dosing and collected during a standardized grief-elicitation methodology. Key outcome measures include changes in the severity of PGD and trauma symptoms, cognitive flexibility, openness to experience, meaning in life and subjective experiences during the psilocybin session. Neural activity will also be evaluated through fMRI to better understand the neurobiological effects of the treatment. This research represents one of the first clinical protocols specifically focused on the potential of psilocybin for treating PGD. The goal is to assess feasibility and safety while laying the groundwork for future randomized controlled trials.